Phenytoin toxicity due to fluoropyrimidines (5FU/capecitabine): three case reports
Open Access
- 12 August 2003
- journal article
- case report
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 89 (4), 615-616
- https://doi.org/10.1038/sj.bjc.6601137
Abstract
Interactions between phenytoin and the fluoropyrimidine derivatives, 5 fluorouracil (5FU) and capecitabine, are not commonly documented or widely recognised. As more people with significant medical comorbidities are now being considered for chemotherapy, it is increasingly likely that people receiving phenytoin will be prescribed treatment with fluoropyrimidines. We present two cases of clinical phenytoin toxicity occurring after starting treatment with 5-fluorouracil/folinic acid (5FU/FA) and a third who developed clinical phenytoin toxicity after starting capecitabine (an orally administered prodrug of fluorouracil).Keywords
This publication has 10 references indexed in Scilit:
- CapecitabineDrugs, 2003
- Phenytoin toxicity as a result of 5-fluorouracil administration.2002
- Dear Doctor: We Really Are Not Sure What Dose of Capecitabine You Should Prescribe for Your PatientJournal of Clinical Oncology, 2002
- Phenytoin and fluorouracil interaction.2001
- Phenytoin and Fluorouracil InteractionAnnals of Pharmacotherapy, 2001
- Severe phenytoin intoxication in a subject homozygous forCYP2C93Clinical Pharmacology & Therapeutics, 2001
- Severe phenytoin intoxication in a subject homozygous for CYP2C9*3Cancer Cell, 2001
- Genetic Polymorphism of the CYP2C Subfamily and Excessive Serum Phenytoin Concentration With Central Nervous System IntoxicationTherapeutic Drug Monitoring, 2000
- Developments in fluoropyrimidine therapy for gastrointestinal cancerCurrent Opinion in Oncology, 1999
- Cytochrome P450 Isozymes and Antiepileptic Drug InteractionsEpilepsia, 1995